发布: 2015年11月20日第5卷第22期 DOI: 10.21769/BioProtoc.1659 浏览次数: 24575
评审: HongLok LungJustine MarsolierAnonymous reviewer(s)
Abstract
The in vitro limiting dilution assay is used to determine the colorectal cancer initiating cell (CC-IC) frequency of a CC-IC enriched suspension culture, grown in growth factor enriched serum free media. The in vivo limiting dilution assay is used to determine the colorectal cancer initiating cell frequency of a primary colorectal cancer sample or an established suspension cell line using immunocompromised murine xenograft models. In vitro and in vivo limiting dilution assays (LDAs) can be used to determine the effect of a specific treatment or genetic knockdown strategy on the initiating cell frequency of a population of CC-ICs or colorectal cancer sample, respectively.
Part I. In vitro CRC LDA
Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2015 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Agro, L. and O’Brien, C. A. (2015). In vitro and in vivo Limiting Dilution Assay for Colorectal Cancer. Bio-protocol 5(22): e1659. DOI: 10.21769/BioProtoc.1659.
分类
癌症生物学 > 癌症干细胞 > 肿瘤形成
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link